Human Chorionic Gonadotropin Market Size - Global Industry, Share, Analysis, Trends and Forecast 2023 - 2032
CHAPTER 1. Industry Overview of Human Chorionic Gonadotropin Market
1.1. Definition and Scope
1.1.1. Definition of Human Chorionic Gonadotropin
1.1.2. Market Segmentation
1.1.3. Years Considered for the Study
1.1.4. Assumptions and Acronyms Used
1.1.4.1. Market Assumptions and Market Forecast
1.1.4.2. Acronyms Used in Global Human Chorionic Gonadotropin Market
1.2. Summary
1.2.1. Executive Summary
1.2.2. Human Chorionic Gonadotropin Market By Technology
1.2.3. Human Chorionic Gonadotropin Market By Therapeutic Area
1.2.4. Human Chorionic Gonadotropin Market By Distribution Channel
1.2.5. Human Chorionic Gonadotropin Market By End-User
1.2.6. Human Chorionic Gonadotropin Market By Region
CHAPTER 2. Research Approach
2.1. Methodology
2.1.1. Research Programs
2.1.2. Market Size Estimation
2.1.3. Market Breakdown and Data Triangulation
2.2. Data Source
2.2.1. Secondary Sources
2.2.2. Primary Sources
CHAPTER 3. Market Dynamics And Competition Analysis
3.1. Market Drivers
3.1.1. Driver 1
3.1.2. Driver 2
3.2. Restraints and Challenges
3.2.1. Restraint 1
3.2.2. Restraint 2
3.3. Growth Opportunities
3.3.1. Opportunity 1
3.3.2. Opportunity 2
3.4. Porter’s Five Forces Analysis
3.4.1. Bargaining Power of Suppliers
3.4.2. Bargaining Power of Buyers
3.4.3. Threat of Substitute
3.4.4. Threat of New Entrants
3.4.5. Degree of Competition
3.5. Market Concentration Ratio and Market Maturity Analysis of Human Chorionic Gonadotropin Market
3.5.1. Go To Market Strategy
3.5.1.1. Introduction
3.5.1.2. Growth
3.5.1.3. Maturity
3.5.1.4. Saturation
3.5.1.5. Possible Development
3.6. Technological Roadmap for Human Chorionic Gonadotropin Market
3.7. Value Chain Analysis
3.7.1. List of Key Manufacturers
3.7.2. List of Customers
3.7.3. Level of Integration
3.8. Cost Structure Analysis
3.8.1. Price Trend of Key Raw Materials
3.8.2. Raw Material Suppliers
3.8.3. Proportion of Manufacturing Cost Structure
3.8.3.1. Raw Material
3.8.3.2. Labor Cost
3.8.3.3. Manufacturing Expense
3.9. Regulatory Compliance
3.10. Competitive Landscape, 2022
3.10.1. Player Positioning Analysis
3.10.2. Key Strategies Adopted By Leading Players
CHAPTER 4. Manufacturing Plant Analysis
4.1. Manufacturing Plant Location and Establish Date of Major Manufacturers in 2022
4.2. R&D Status of Major Manufacturers in 2022
CHAPTER 5. Human Chorionic Gonadotropin Market By Technology
5.1. Introduction
5.2. Human Chorionic Gonadotropin Revenue By Technology
5.2.1. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast, By Technology, 2020-2032
5.2.2. Natural Source Extraction
5.2.2.1. Natural Source Extraction Market Revenue (USD Million) and Growth Rate (%), 2020-2032
5.2.3. Recombinant Technology
5.2.3.1. Recombinant Technology Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 6. Human Chorionic Gonadotropin Market By Therapeutic Area
6.1. Introduction
6.2. Human Chorionic Gonadotropin Revenue By Therapeutic Area
6.2.1. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast, By Therapeutic Area, 2020-2032
6.2.2. Female Infertility Treatment
6.2.2.1. Female Infertility Treatment Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.3. Male Hypogonadism
6.2.3.1. Male Hypogonadism Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.4. Oligospermia Treatment
6.2.4.1. Oligospermia Treatment Market Revenue (USD Million) and Growth Rate (%), 2020-2032
6.2.5. Others
6.2.5.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 7. Human Chorionic Gonadotropin Market By Distribution Channel
7.1. Introduction
7.2. Human Chorionic Gonadotropin Revenue By Distribution Channel
7.2.1. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast, By Distribution Channel, 2020-2032
7.2.2. Hospital Pharmacies
7.2.2.1. Hospital Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.3. Retail Pharmacies
7.2.3.1. Retail Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
7.2.4. Online Pharmacies
7.2.4.1. Online Pharmacies Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 8. Human Chorionic Gonadotropin Market By End-User
8.1. Introduction
8.2. Human Chorionic Gonadotropin Revenue By End-User
8.2.1. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast, By End-User, 2020-2032
8.2.2. Fertility Clinics
8.2.2.1. Fertility Clinics Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.3. Research Institutions
8.2.3.1. Research Institutions Market Revenue (USD Million) and Growth Rate (%), 2020-2032
8.2.4. Others
8.2.4.1. Others Market Revenue (USD Million) and Growth Rate (%), 2020-2032
CHAPTER 9. North America Human Chorionic Gonadotropin Market By Country
9.1. North America Human Chorionic Gonadotropin Market Overview
9.2. U.S.
9.2.1. U.S. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
9.2.2. U.S. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
9.2.3. U.S. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.2.4. U.S. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
9.3. Canada
9.3.1. Canada Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
9.3.2. Canada Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
9.3.3. Canada Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
9.3.4. Canada Canada Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
9.4. North America PEST Analysis
CHAPTER 10. Europe Human Chorionic Gonadotropin Market By Country
10.1. Europe Human Chorionic Gonadotropin Market Overview
10.2. U.K.
10.2.1. U.K. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
10.2.2. U.K. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
10.2.3. U.K. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.2.4. U.K. Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
10.3. Germany
10.3.1. Germany Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
10.3.2. Germany Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
10.3.3. Germany Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.3.4. Germany Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
10.4. France
10.4.1. France Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
10.4.2. France Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
10.4.3. France Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.4.4. France Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
10.5. Spain
10.5.1. Spain Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
10.5.2. Spain Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
10.5.3. Spain Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.5.4. Spain Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
10.6. Rest of Europe
10.6.1. Rest of Europe Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
10.6.2. Rest of Europe Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
10.6.3. Rest of Europe Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
10.6.4. Rest of Europe Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
10.7. Europe PEST Analysis
CHAPTER 11. Asia Pacific Human Chorionic Gonadotropin Market By Country
11.1. Asia Pacific Human Chorionic Gonadotropin Market Overview
11.2. China
11.2.1. China Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
11.2.2. China Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
11.2.3. China Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.2.4. China Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
11.3. Japan
11.3.1. Japan Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
11.3.2. Japan Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
11.3.3. Japan Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.3.4. Japan Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
11.4. India
11.4.1. India Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
11.4.2. India Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
11.4.3. India Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.4.4. India Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
11.5. Australia
11.5.1. Australia Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
11.5.2. Australia Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
11.5.3. Australia Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.5.4. Australia Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
11.6. South Korea
11.6.1. South Korea Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
11.6.2. South Korea Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
11.6.3. South Korea Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.6.4. South Korea Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
11.7. Rest of Asia-Pacific
11.7.1. Rest of Asia-Pacific Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
11.7.2. Rest of Asia-Pacific Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
11.7.3. Rest of Asia-Pacific Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
11.7.4. Rest of Asia-Pacific Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
11.8. Asia Pacific PEST Analysis
CHAPTER 12. Latin America Human Chorionic Gonadotropin Market By Country
12.1. Latin America Human Chorionic Gonadotropin Market Overview
12.2. Brazil
12.2.1. Brazil Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
12.2.2. Brazil Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
12.2.3. Brazil Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.2.4. Brazil Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
12.3. Mexico
12.3.1. Mexico Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
12.3.2. Mexico Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
12.3.3. Mexico Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.3.4. Mexico Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
12.4. Rest of Latin America
12.4.1. Rest of Latin America Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
12.4.2. Rest of Latin America Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
12.4.3. Rest of Latin America Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
12.4.4. Rest of Latin America Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
12.5. Latin America PEST Analysis
CHAPTER 13. Middle East & Africa Human Chorionic Gonadotropin Market By Country
13.1. Middle East & Africa Human Chorionic Gonadotropin Market Overview
13.2. GCC
13.2.1. GCC Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
13.2.2. GCC Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
13.2.3. GCC Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.2.4. GCC Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
13.3. South Africa
13.3.1. South Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
13.3.2. South Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
13.3.3. South Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.3.4. South Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
13.4. Rest of Middle East & Africa
13.4.1. Rest of Middle East & Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Technology, 2020-2032
13.4.2. Rest of Middle East & Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Therapeutic Area, 2020-2032
13.4.3. Rest of Middle East & Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By Distribution Channel, 2020-2032
13.4.4. Rest of Middle East & Africa Human Chorionic Gonadotropin Revenue (USD Million) and Forecast By End-User, 2020-2032
13.5. Middle East & Africa PEST Analysis
CHAPTER 14. Player Analysis Of Human Chorionic Gonadotropin Market
14.1. Human Chorionic Gonadotropin Market Company Share Analysis
14.2. Competition Matrix
14.2.1. Competitive Benchmarking of key players by price, presence, market share, and R&D investment
14.2.2. New Product Launches and Product Enhancements
14.2.3. Mergers And Acquisition In Global Human Chorionic Gonadotropin Market
14.2.4. Partnership, Joint Ventures and Strategic Alliances/ Sales Agreements
CHAPTER 15. Company Profile
15.1. Bristol Myers Squibb Company
15.1.1. Company Snapshot
15.1.2. Business Overview
15.1.3. Financial Overview
15.1.3.1. Revenue (USD Million), 2022
15.1.3.2. Bristol Myers Squibb Company 2022 Human Chorionic Gonadotropin Business Regional Distribution
15.1.4. Product /Service and Specification
15.1.5. Recent Developments & Business Strategy
15.2. Cigna
15.3. Merck & Co., Inc.
15.4. Fresenius Kabi AG
15.5. Sun Pharmaceutical Industries Ltd
15.6. Ferring Pharmaceuticals Inc
15.7. Scripps Laboratories
15.8. Lee BioSolutions Inc.
15.9. Sanzyme
15.10. LUPIN
Frequently Asked Questions
What was the market size of the global human chorionic gonadotropin in 2022?
The market size of human chorionic gonadotropin was USD 812.7 million in 2022.
What is the CAGR of the global human chorionic gonadotropin market from 2023 to 2032?
The CAGR of human chorionic gonadotropin is 7.5% during the analysis period of 2023 to 2032.
Which are the key players in the human chorionic gonadotropin market?
The key players operating in the global market are including Bristol Myers Squibb Company, Cigna, Merck & Co., Inc., Fresenius Kabi AG, Sun Pharmaceutical Industries Ltd, Ferring Pharmaceuticals Inc, Scripps Laboratories, Lee BioSolutions Inc., Sanzyme, and LUPIN.
Which region dominated the global human chorionic gonadotropin market share?
North America held the dominating position in human chorionic gonadotropin industry during the analysis period of 2023 to 2032.
Which region registered fastest CAGR from 2023 to 2032?
Asia-Pacific region exhibited fastest growing CAGR for market of human chorionic gonadotropin during the analysis period of 2023 to 2032.
What are the current trends and dynamics in the global Human Chorionic Gonadotropin industry?
The current trends and dynamics in the human chorionic gonadotropin industry include the significant increase in infertility issues among men and women, the rise in the prevalence of hypogonadism in the geriatric population, increase in awareness toward HCG among healthcare professionals and patients, and changing lifestyle and awareness regarding the treatment of infertility.
Which technology held the maximum share in 2022?
The natural source extraction technology held the maximum share of the human chorionic gonadotropin industry.
Select Licence Type
Connect with our sales team
Why Acumen Research And Consulting
100%
Customer Satisfaction
24x7
Availability - we are always there when you need us
200+
Fortune 50 Companies trust Acumen Research and Consulting
80%
of our reports are exclusive and first in the industry
100%
more data and analysis
1000+
reports published till date
